Document is current
Any future updates will be listed below
-
Authors
Stripecke, Renata https://orcid.org/0000-0001-7756-8460
Münz, Christian https://orcid.org/0000-0001-6419-1940
Schuringa, Jan Jacob https://orcid.org/0000-0001-8452-8555
Bissig, Karl‐Dimiter
Soper, Brian
Meeham, Terrence
Yao, Li‐Chin
Di Santo, James P
Brehm, Michael
Rodriguez, Estefania
Wege, Anja Kathrin
Bonnet, Dominique
Guionaud, Silvia
Howard, Kristina E
Kitchen, Scott
Klein, Florian
Saeb‐Parsy, Kourosh
Sam, Johannes
Sharma, Amar Deep
Trumpp, Andreas https://orcid.org/0000-0002-6212-3466
Trusolino, Livio
Bult, Carol
Shultz, Leonard
-
Funding
Funding for this research was provided by:
Deutsches Zentrum für Infektionsforschung (TTU 07.815)
Else Kroener Fresenius Stiftung (2017 T04)
HHS | NIH | NIH Office of the Director (R24 ODO26440)
HHS | NIH | National Cancer Institute (CA031496)
HHS | NIH | National Cancer Institute (U01 CA224013)
National Institute of Diabetes and Digestive and Kidney Diseases (DK104218)
National Institute of Allergy and Infectious Diseases (AI32963)
- License Information
-
More Information
Article History
Received: 14 December 2019
Revised: 29 April 2020
Accepted: 14 May 2020
First Online: 24 June 2020
Conflict of interest
: JAX is a not‐for‐profit organization that commercially distributes several of the mentioned immune‐deficient mouse strains and PDX models, deposited in the repository. BS, LCY, CB, and LS are JAX employees. RS and MB receive research funding from JAX. The other authors declare no competing interests.
